CN107114775A - 一种基于鮸鱼鱼鳔多肽的降血脂复配物及其制备方法 - Google Patents
一种基于鮸鱼鱼鳔多肽的降血脂复配物及其制备方法 Download PDFInfo
- Publication number
- CN107114775A CN107114775A CN201710326637.3A CN201710326637A CN107114775A CN 107114775 A CN107114775 A CN 107114775A CN 201710326637 A CN201710326637 A CN 201710326637A CN 107114775 A CN107114775 A CN 107114775A
- Authority
- CN
- China
- Prior art keywords
- air bladder
- brown croaker
- reducing blood
- blood lipid
- croaker air
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004712 air sac Anatomy 0.000 title claims abstract description 53
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 48
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 48
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 48
- 241001417494 Sciaenidae Species 0.000 title claims abstract description 46
- 239000008280 blood Substances 0.000 title claims abstract description 44
- 210000004369 blood Anatomy 0.000 title claims abstract description 44
- -1 lipid compound Chemical class 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 150000001875 compounds Chemical class 0.000 claims abstract description 21
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 claims abstract description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 18
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 13
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 10
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 10
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 10
- 229930182490 saponin Natural products 0.000 claims abstract description 10
- 150000007949 saponins Chemical class 0.000 claims abstract description 10
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 claims abstract description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 9
- 229960002045 bergapten Drugs 0.000 claims abstract description 9
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000021323 fish oil Nutrition 0.000 claims abstract description 9
- 229960001867 guaiacol Drugs 0.000 claims abstract description 9
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 9
- 239000011718 vitamin C Substances 0.000 claims abstract description 9
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 9
- 229940088598 enzyme Drugs 0.000 claims description 9
- 150000002632 lipids Chemical class 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 7
- 238000011282 treatment Methods 0.000 claims description 7
- 239000007853 buffer solution Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 5
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 5
- 238000010612 desalination reaction Methods 0.000 claims description 5
- 239000011347 resin Substances 0.000 claims description 5
- 229920005989 resin Polymers 0.000 claims description 5
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 5
- 239000004471 Glycine Substances 0.000 claims description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 4
- 239000004365 Protease Substances 0.000 claims description 4
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 claims description 4
- 235000004279 alanine Nutrition 0.000 claims description 4
- 235000003704 aspartic acid Nutrition 0.000 claims description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 4
- 238000013329 compounding Methods 0.000 claims description 4
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 4
- 235000013922 glutamic acid Nutrition 0.000 claims description 4
- 239000004220 glutamic acid Substances 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 229960002591 hydroxyproline Drugs 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 4
- 239000007919 dispersible tablet Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 108090000526 Papain Proteins 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 235000019834 papain Nutrition 0.000 claims description 2
- 229940055729 papain Drugs 0.000 claims description 2
- 241001233037 catfish Species 0.000 claims 1
- 239000003292 glue Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 210000005013 brain tissue Anatomy 0.000 abstract description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 6
- 210000005003 heart tissue Anatomy 0.000 abstract description 6
- 108010007622 LDL Lipoproteins Proteins 0.000 abstract description 5
- 102000007330 LDL Lipoproteins Human genes 0.000 abstract description 5
- 230000004089 microcirculation Effects 0.000 abstract description 4
- 150000001413 amino acids Chemical class 0.000 abstract description 3
- 230000036772 blood pressure Effects 0.000 abstract description 3
- 210000004351 coronary vessel Anatomy 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 101000659079 Homo sapiens Synaptoporin Proteins 0.000 abstract description 2
- 102000054423 human SYNPR Human genes 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 150000003626 triacylglycerols Chemical class 0.000 description 6
- 201000005577 familial hyperlipidemia Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 108010010234 HDL Lipoproteins Proteins 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 244000189799 Asimina triloba Species 0.000 description 2
- 235000006264 Asimina triloba Nutrition 0.000 description 2
- 235000009467 Carica papaya Nutrition 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002402 anti-lipaemic effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 229960005370 atorvastatin Drugs 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000003998 size exclusion chromatography high performance liquid chromatography Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710326637.3A CN107114775B (zh) | 2017-05-10 | 2017-05-10 | 一种基于鮸鱼鱼鳔多肽的降血脂复配物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710326637.3A CN107114775B (zh) | 2017-05-10 | 2017-05-10 | 一种基于鮸鱼鱼鳔多肽的降血脂复配物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107114775A true CN107114775A (zh) | 2017-09-01 |
CN107114775B CN107114775B (zh) | 2020-10-16 |
Family
ID=59728196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710326637.3A Active CN107114775B (zh) | 2017-05-10 | 2017-05-10 | 一种基于鮸鱼鱼鳔多肽的降血脂复配物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107114775B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108095125A (zh) * | 2017-12-12 | 2018-06-01 | 浙江海洋大学 | 一种保肝护肝的鮸鱼鱼鳔多肽保健食品及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102961445A (zh) * | 2012-11-23 | 2013-03-13 | 西安泰科迈医药科技有限公司 | 一种用于辅助降血脂、辅助降血压的药物组合物及其胶囊制备方法 |
CN103992385A (zh) * | 2014-05-22 | 2014-08-20 | 浙江海洋学院 | 一种大黄鱼鱼鳔抗氧化胶原肽及其制备方法和用途 |
-
2017
- 2017-05-10 CN CN201710326637.3A patent/CN107114775B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102961445A (zh) * | 2012-11-23 | 2013-03-13 | 西安泰科迈医药科技有限公司 | 一种用于辅助降血脂、辅助降血压的药物组合物及其胶囊制备方法 |
CN103992385A (zh) * | 2014-05-22 | 2014-08-20 | 浙江海洋学院 | 一种大黄鱼鱼鳔抗氧化胶原肽及其制备方法和用途 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108095125A (zh) * | 2017-12-12 | 2018-06-01 | 浙江海洋大学 | 一种保肝护肝的鮸鱼鱼鳔多肽保健食品及其制备方法 |
CN108095125B (zh) * | 2017-12-12 | 2021-05-18 | 浙江海洋大学 | 一种保肝护肝的鮸鱼鱼鳔多肽保健食品及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107114775B (zh) | 2020-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102885856B (zh) | 用美洲大蠊提取物生产治疗乙型肝炎药物的生产方法 | |
CN109090597A (zh) | 一种辅助降三高组合物及其制备方法和应用 | |
CN108175024A (zh) | 一种向日葵花粉固体饮料及制备方法 | |
CN110478235A (zh) | 一种腹泻灸及其制备方法 | |
CN104161864B (zh) | 一种健脾益胃的外用膏药及其制备方法 | |
CN107114775A (zh) | 一种基于鮸鱼鱼鳔多肽的降血脂复配物及其制备方法 | |
CN102018158A (zh) | 一种芦荟果酱 | |
WO2015027730A1 (zh) | 显著升高血清高密度脂蛋白浓度的中药复合组合物和制备方法 | |
CN1738633A (zh) | 来自药用植物的抗肥胖组分及其组合物 | |
CN102038095A (zh) | 用于预防和治疗鸡肝病变的中药饲料添加剂 | |
CN109043325A (zh) | 一种食用复合菌粉 | |
CN103549483A (zh) | 保健鳄鱼食品 | |
CN101979003A (zh) | 一种抗瘤中药 | |
CN105832787A (zh) | 一种三七西洋参复合制剂及其制备方法与应用 | |
CN1045892C (zh) | 防治冠心病心绞痛的中药制剂 | |
CN108783443A (zh) | 一种用于脏腑调理的片剂及其制备方法 | |
CN103549505A (zh) | 保健带鱼食品 | |
CN103417616B (zh) | 一种抗疣中药精华素及其提取工艺 | |
CN1179328A (zh) | 一种治疗糖尿病的药剂、食品及制作方法 | |
CN1201769C (zh) | 治疗糖尿病、肾病的药物 | |
KR20100129040A (ko) | 미생물을 이용한 우황 청심원 원료 함유 건강식품의 제조방법 및 그 제조방법에 의해 제조된 건강식품 | |
CN104689116B (zh) | 一种治疗风寒感冒的大鲵复方制剂及其制备方法 | |
CN1682981A (zh) | 治疗脑癌的蛇毒胶囊及制备方法 | |
CN105395574A (zh) | 一种药食两用防治心脑血管病复方角鲨烯鱼油软胶囊 | |
CN108707535A (zh) | 一种白芨保健醋及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230615 Address after: Room 25A, Room 032, Jinshi Building, Shishan Road, High tech Zone, Suzhou City, Jiangsu Province, 215000 Patentee after: Suzhou Qicheng Biochemical Technology Research and Development Co.,Ltd. Address before: 316022 No. 1, Haida South Road, Lincheng street, Dinghai District, Zhoushan, Zhejiang Patentee before: Zhejiang Ocean University Effective date of registration: 20230615 Address after: Room 238, 2nd Floor, Building 6, No. 2 East Binhe Road, Youanmenwai, Fengtai District, Beijing, 100071 Patentee after: Beijing Institute of Traditional Chinese Medicine Address before: Room 25A, Room 032, Jinshi Building, Shishan Road, High tech Zone, Suzhou City, Jiangsu Province, 215000 Patentee before: Suzhou Qicheng Biochemical Technology Research and Development Co.,Ltd. |